In order to determine whether anti-VEGF and anti-EGFR antibodies could suppress the activation of these signaling effectors, we examined the expression of c-Myc, NF-κB/p65 and IκBα in CRC cell tumors by western blot. The gene discussed is EGFR; the disease is colorectal carcinoma.